{"database": "lobbying", "table": "lobbying_activities", "rows": [[2646956, "7fcfa42e-7a57-4e0e-bf45-d7c0f7791c80", "2A", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2021, "second_quarter", "MMM", "Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, prescription drug access and affordability, transparency, international reference pricing, Stark & anti-kickback policies, home infusion, covid therapeutics and Medicare drug card\n\nH.R. 1319, American Rescue Plan of 2021 implementation", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 80000, null, 0, 0, "2021-07-19T14:05:28.917000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2646956"], "units": {}, "query_ms": 0.31639705412089825, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}